Coya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.84

+0.42 (+9.50%)

As of Feb 8, 2:11 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +661.4% upside

Low Target $27.29

Average Target $36.85

High Target $45.13

Current Price $4.84

Current
$4.84

Target
$36.85

$27.29 $36.85 avg $45.13

Scenario Analysis

Bear Case

$27.29

463.8%

Low target

Base Case

$36.85

+661.4%

Avg target

Bull Case

$45.13

+832.4%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$35.71

-86.4% from high

52-Week Low

$23.31

+-79.2% from low

Target vs 52W High

$36.85

+3.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%